DJIA 17,619.51 23.16 0.13%
NASDAQ 4,986.87 28.40 0.57%
S&P 500 2,063.11 5.47 0.27%
market minute promo

Johnson & Johnson (NYSE: JNJ)

97.46 -0.22 (-0.23%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JNJ $97.46 -0.23%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $98.43
Previous Close $97.68
Daily Range $97.30 - $98.45
52-Week Range $95.10 - $109.49
Market Cap $270.3B
P/E Ratio 17.47
Dividend (Yield) $3.00 (3.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 8,956,530
Average Daily Volume 7,745,769
Current FY EPS $6.14




Drug Makers

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website:

News & Commentary

This Biotech Stock Has Jaw-Dropping Growth Potential

Geron Corp. is small-cap biotech with major growth potential.

Intercept Pharmaceuticals Files for OCA in U.S. and Europe - Analyst Blog

Intercept Pharmaceuticals Files for OCA in U.S. and Europe - Analyst Blog

Stock Market News for June 30, 2015 - Market News

Has Johnson & Johnson’s Stock Peaked?

Are Dividend Growth Investors Livin' Too Large?

Retirement Strategy: While Greece Implodes, My Income Keeps Paying The Bills Just Fine And Dandy

Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 01, 2015

Johnson & Johnson's New Drug Invega Trinza Will Help Drive Pharma Sales

Will Incoming Threats Sink Johnson & Johnson?

J&J is a massive cruise ship in the pharmaceutical industry, but there are plenty of fast-moving sharks skimming around its waters. Which of them do we need to be worried about?

Geron Is Ripe For A Short Squeeze

See More JNJ News...

JNJ's Top Competitors

JNJ $97.46 (-0.23%)
Current stock: JNJ
PFE $33.53 (-0.18%)
Current stock: PFE
MRK $56.93 (-0.63%)
Current stock: MRK
BSX $17.70 (-0.62%)
Current stock: BSX